Updated

Updated · Forbes · Aug 6

Amazon Pharmacy Cuts Medicare GLP-1 Costs to $50 a Month, Slashing Prices Up to 97%

Updated

Updated · Forbes · Aug 6

Amazon Pharmacy Cuts Medicare GLP-1 Costs to $50 a Month, Slashing Prices Up to 97%

Q: Why is Amazon offering highly coveted GLP-1 weight-loss drugs for just $50, and what hidden catch awaits Medicare patients?

Amazon is not independently subsidizing these expensive drugs out of generosity; it is using a temporary federal program to attract Medicare patients into its pharmacy ecosystem. The $50 price comes from the CMS-run Medicare GLP-1 Bridge program, which began July 1, 2026 and runs through December 31, 2027. Amazon’s role is to make enrollment and fulfillment frictionless by handling eligibility checks, prior authorization, claims processing, and delivery, while gaining customers for its broader pharmacy and One Medical businesses. The catch is that the offer is much narrower than it sounds. It is only for eligible Medicare Part D patients using certain GLP-1s for weight loss, not for diabetes or other conditions. If a patient has a diagnosis such as type 2 diabetes, sleep apnea, fatty liver disease, heart disease, or another condition that could make a GLP-1 coverable under their regular Part D plan, they generally cannot use the Bridge program, even if their own copay is higher than $50 or their plan denied payment. There are other limits patients may not notice. The program covers only Wegovy, Foundayo, and Zepbound KwikPen; single-dose Zepbound pens and vials are excluded. It covers only 28- or 30-day supplies, not 90-day fills, and for Zepbound KwikPen, pen needles are not included. Most importantly, the $50 paid through Bridge does not count toward a patient’s Part D deductible or annual out-of-pocket cap because the program sits outside normal Part D coverage.

3 articles · Updated · Forbes · Aug 6

$50-a-month pricing now lets eligible Medicare patients get Wegovy, Zepbound KwikPen and Eli Lilly's Foundayo through Amazon Pharmacy under the federal GLP-1 Bridge Program through Dec. 31, 2027.
Prices had run $1,200 to $1,500 a month, and Amazon said the reduction could save customers about $300 million after high costs had kept the drugs out of reach for millions.
Amazon said it will automate eligibility checks, prior authorization and billing once a prescription is sent electronically, while offering same-day delivery in more than 3,100 U.S. cities without requiring Prime.
The move deepens a fast-moving GLP-1 price war after CVS cut digital weight-loss visits to $29 and Walmart expanded pharmacy support, while Medicare's July 1 bridge program shifts the first 18 months of financial risk to CMS.